Trimipramine-d3 maleate structure
|
Common Name | Trimipramine-d3 maleate | ||
---|---|---|---|---|
CAS Number | 1185245-93-5 | Molecular Weight | 410.506 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C24H30N2O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 9℃ | |
Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger |
Use of Trimipramine-d3 maleateTrimipramine-d3 maleate is the deuterium labeled Trimipramine maleate. Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively[1][2]. |
Name | UNII:269K6498LD |
---|---|
Synonym | More Synonyms |
Description | Trimipramine-d3 maleate is the deuterium labeled Trimipramine maleate. Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C24H30N2O4 |
---|---|
Molecular Weight | 410.506 |
Flash Point | 9℃ |
Exact Mass | 410.220551 |
Storage condition | 2-8°C |
Symbol |
GHS02, GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H301 + H311 + H331-H370 |
Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
Hazard Codes | F,T |
Risk Phrases | 11-23/24/25-39/23/24/25 |
Safety Phrases | 7-16-36/37-45 |
RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,β-trimethyl-, (2Z)-2-butenedioate (1:1) |
UNII:269K6498LD |
UNII:D28E1043W5 |
3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine (2Z)-but-2-enedioate (1:1) |
3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethyl-1-propanamine (2Z)-2-butenedioate (1:1) |
UNII:I412286V22 |